Nigeria’s pharmaceutical industry is at the cusp of a major transformation, fuelled by rising healthcare demand, innovative local players, and emergent government policies aimed at reducing the country’s dependence on imports. Corporate players are jockeying to take advantage of this changing pa
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
